March 16, 2026
We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.
Oxford PharmaGenesis celebrated the official opening of its newest regional office on 27 February by holding a launch event at Melbourne’s Bio21 Institute. The attendee list included representatives from: current and potential client companies; universities and hospitals; the Victorian state government; partner organizations; and patient groups.
To mark Rare Disease Day 2020, Oxford PharmaGenesis held a series of talks in the Oxford office that focused on the patients’ perspective of living with a rare disease. Colleagues from the Oxford Central, London, Cardiff, Cambridge and Philadelphia offices dialled in to take part.
In January 2020 over 350 medical publication professionals from across industry, publishers and agencies came together in London to attend the European meeting of ISMPP; we were there as a 10-strong team to experience first hand the engaging programme on offer. We were also lucky enough to have six posters accepted, including two oral poster…
During a busy week for Oxford PharmaGenesis, a successful Open Pharma roundtable and ISMPP EU conference were followed by a plenary presentation at the opening session of CBI’s 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries Conference in Miami, FL, USA (22–24 January 2020).
Oxford PharmaGenesis is proud to announce that its annual charity donation is being made to Evidence Aid, an Oxford-based global charity that champions evidence-based humanitarian action in places threatened by disaster.
Oxford PharmaGenesis was delighted to attend the West Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 14 and 15 November 2019 in San Diego, CA, USA.
